These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry. Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282 [TBL] [Abstract][Full Text] [Related]
8. Bioaffinity chromatography on monolithic supports. Tetala KK; van Beek TA J Sep Sci; 2010 Feb; 33(3):422-38. PubMed ID: 20099259 [TBL] [Abstract][Full Text] [Related]
9. Screening for peptide affinity ligands on CIM monoliths. Pflegerl K; Podgornik A; Berger E; Jungbauer A Biotechnol Bioeng; 2002 Sep; 79(7):733-40. PubMed ID: 12209796 [TBL] [Abstract][Full Text] [Related]
10. Recombinant protein purification using complementary peptides as affinity tags. Martínez-Ceron MC; Targovnik AM; Urtasun N; Cascone O; Miranda MV; Camperi SA N Biotechnol; 2012 Jan; 29(2):206-10. PubMed ID: 21664994 [TBL] [Abstract][Full Text] [Related]
11. Para-aminobenzamidine linked regenerated cellulose membranes for plasminogen activator purification: effect of spacer arm length and ligand density. Fasoli E; Reyes YR; Guzman OM; Rosado A; Cruz VR; Borges A; Martinez E; Bansal V J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 930():13-21. PubMed ID: 23703544 [TBL] [Abstract][Full Text] [Related]
12. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator. Bakker AH; Nieuwenbroek NM; Verheijen JH Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642 [TBL] [Abstract][Full Text] [Related]
13. Current trends in affinity-based monoliths in microextraction approaches: A review. Vergara-Barberán M; Carrasco-Correa EJ; Lerma-García MJ; Simó-Alfonso EF; Herrero-Martínez JM Anal Chim Acta; 2019 Nov; 1084():1-20. PubMed ID: 31519228 [TBL] [Abstract][Full Text] [Related]
14. Development of L-histidine immobilized CIM(®) monolithic disks for purification of immunoglobulin G. Prasanna RR; Kamalanathan AS; Vijayalakshmi MA J Mol Recognit; 2015 Mar; 28(3):129-41. PubMed ID: 25645349 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of factor VIII. Kelley BD; Tannatt M; Magnusson R; Hagelberg S; Booth J Biotechnol Bioeng; 2004 Aug; 87(3):400-12. PubMed ID: 15281114 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding. Jiao J; Yu M; Ru B Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor. Lijnen HR; De Cock F; Collen D Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373 [TBL] [Abstract][Full Text] [Related]
20. Affinity purification and enzymatic cleavage of inter-alpha inhibitor proteins using antibody and elastase immobilized on CIM monolithic disks. Lim YP; Josic D; Callanan H; Brown J; Hixson DC J Chromatogr A; 2005 Feb; 1065(1):39-43. PubMed ID: 15782948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]